High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34+ PBSC in patients undergoing high-dose chemotherapy and stem cell rescue

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 2, 2000, Pages 285-293

  Gazitt, Yair ^a,b   Liu, Qun ^a  

^a Department of Medicine/Hematology ^*  (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOMA; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTAPHERESIS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIPLE MYELOMA; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC;

EID: 0034071996     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600319513     Document Type: Article

References (34)

1. Bender JG, SF Williams, S Myers, D Nottleman, WJ Lee, KL Unverzagt, D Walker, LB To, and DE Van Epps. (1992). Characterization of chemotherapy-mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant 10:281-285.
2. Kotasek D, KM Shepherd, RE Sage, BM Dale, JE Norman, P Charles, A Gregg, A Pillow and A Bolton. (1992). Factors affecting blood stem cell collection following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 9:11-17.
3. Molineux G, Z Pojda, IN Hampson, BI Lord and TM Dexter. (1990). Transplantation potential of peripheral blood stem cells induced by G-CSF. Blood 76:2153-2158.
4. Demirer T, CD Buckner and WI Bensinger. (1996). Optimization of stem cell mobilization. Stem Cells 14:106-116.
5. Pettengell R, N Tetsa, R Swindell, D Crowther and T Dexter. (1992). Transplantation of hematopoietic cells released into the peripheral blood for non-Hodgkin's lymphoma. Blood 82:2239-2248.
6. Gazitt Y, CO Freytes, N Callander, T-W Tsai, M Alsina, J Anderson, L Holle, J Cruz, P Devore, M McGrath, G West, R Alvarez and W Montgomery. (1999). Successful PBSC mobilization with high dose G-CSF for patients failing a first round of mobilization. J Hematother 8:173-183.
7. + cells during leukapheresis allows a single, successful collection of hematopoietic progenitors in patients with low numbers of circulating stem cells. Bone Marrow Transplant 23:1229-1236.
8. Vora AJ, CH Toh, J Peel and M Greaves. (1994). Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration. Br J Haematol 86:180-182.
9. Brugger W, KJ Bross, M Glatt, F Weber, L Mertlsman and L Kanz. (1994). Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636-640.
10. Shpall EJ, and R Jones. (1994). Release of tumor cells from bone marrow. Blood 83:623-625.
11. Gazitt Y, and CL Reading. (1996). Autologous transplantation with tumor-free graft: a model for multiple myeloma patients. Leuk Lymphoma 23:203-212.
12. Gazitt Y, E Tian, B Barlogie, CL Reading, DH Vesole, S Jagannath, J Schnell, R Hoffman and G Tricot. (1996). Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and GM-CSF. Blood 87:805-811.
13. Bensinger W, J Singer, F Applebaum, K Lilleby, K Longin, S Rowley, E Clarke, R Clift, J Hansen, T Shields, R Storb, C Weaver, P Weiden and CD Buckner. (1993). Autologous transplantation with peripheral blood mononuclear cells after administration of G-CSF. Blood 81:3158-3163.
14. Bensinger WL, F Applebaum, S Rowley, R Storb, J Sanders, K Lilleby, T Gooley, T Demirer, K Schiffman, C Weaver, R Clift, T Chauncey, J Klarnet, T Montgomery, S Petersdorf, P Weiden, R Witherspoon and CD Buckner. (1995). Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13:2547-2555.
15. + cell yields. J Hematother 7:241-249.
16. Haas R, R Mohle, S Fruhauf, H Goldschmidt, B Will, M Flentje, M Wannenmacher and W Hanstein. (1994). Patient characteristic associated with successful mobilization and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787-3794.
17. Tricot G, S Jagannath, D Vesole, J Nelson, S Tindel, L Miller, B Cheson, J Crowley and B Barlogie. (1995). Peripheral blood stem cell transplant for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588-596.
18. Haas R, M Moos, R Mohle, H Dohner, B Witt, H Goldschmidt, S Murea, M Flentje, M Wannenmacher and W Hunstein. (1996). High-dose therapy with peripheral blood progenitor cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 17:149-155.
19. Watts MJ, AM Sullivan, E Jamieson, R Pearce, A Fielding, S Devereux, AH Goldstone and DC Linch. (1997). Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 15:535-546.
20. Pollard Y, MJ Watts, D Grant, N Chevda, DC Linch and SJ Machin. (1999). Use of the haematopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. B J Haematol 106:538-544.
21. + counts and apheresis planning. Hematol Oncol 16:69-75.
22. Armitage S, R Hargreaves, D Samson, M Brennan, E Kanfer and C Navarrete. (1997). CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 20:587-591.
23. + cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patients. Klin Padiatr 209:186-190.
24. + cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 17:509-515.
25. + cell enumeration in the peripheral blood and apheresis samples using 2 laboratory diagnostic kits, or an institutional protocol. Bone Marrow Transplant 23:378-388.
26. + progenitor cell collection in patients with hematological malignancies. Am J Hematol 58:255-262.
27. Brasel K, HJ McKena, K Charrier, PJ Morrissey, DE Williams and SD Lyman. (1997). flt3-ligand synergized with GM-CSF or G-CSF to mobilize hematopoietic stem cells into the peripheral blood in mice. Blood 90:3781-3788.
28. Ramsfjell V, OJ Borge, P Veiby, J Cardier, MJ Murphy, SD Lyman, S Lok and SEW Jacobsen. (1996). Thrombopoietin but not erythropoietin directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interaction with the ligand of c-kit and flt3. Blood 88:4481-4492.
29. + dendritic cell precursors. Blood 93:2244-2252.
30. Lyman SD, M Seaberg, R Hanna, J Zappone, K Brasel, JL Abkowitz, JT Prchal, JC Schultz and NT Shahiti. (1995). Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood 86:4091-4096.
31. Wodnar-Filipowicz A, SD Lyman, A Gratwohl, A Tichelli, B Speck and C Nissen. (1996). flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 88:4493-4499, 1066.
32. Chklovskaia E, W Jansen, C Nissen, SD Lyman, C Rahner, L Landman and A Wodnar-Philipowicz. (1999). Mechanism of flt3 ligand expression in bone marrow failure: translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis. Blood 93:2595-2604.
33. + cell determination by flow cytometry. J Hematother 5:213-226.
34. + hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 34:128-133.